Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Task-oriented rehab program does not result in greater recovery from stroke

  • Study sheds light on source of drug addicts risk-taking behavior

  • Exercise and meditation together help beat depression

  • Overconfidence, loss aversion are key predictors for investment mistakes

  • Two in five individuals with schizophrenia have attempted suicide

  • Epilepsy at the molecular level

  • Childhood maltreatment predicts range of negative outcomes in bipolar patients

  • Prelinguistic infants can categorize colors

  • New study reveals visual working memory may provide clues to autism's social struggles

  • Beliefs about all-knowing gods fosters co-operation

  •